Krystal Biotech Other Long Term Liabilities (Quarterly) Analysis

Krystal Biotech, Inc. (KRYS)

291.75 -0.18 (-0.06%) USD | NASDAQ | Jan 14, 10:37

View Other Long Term Liabilities (Quarterly) for KRYS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

DexCom, Inc.	Upgrade
BioLife Solutions, Inc.	--
Alnylam Pharmaceuticals, Inc.	Upgrade
Catalyst Pharmaceuticals, Inc.	Upgrade
Amicus Therapeutics, Inc.	Upgrade